{"database": "lobbying", "table": "lobbying_activities", "rows": [[3243708, "101b59ad-1200-4e42-b28c-38372cad25f4", "3T", "HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC", 17966, "EMERGENT BIOSOLUTIONS", 2024, "third_quarter", "DIS", "Draft - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 - Title II - Department of Health and Human Services - funding and policy for development, acquisition, and procurement of medical countermeasures for the Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; H.R. 6243 - Overdose Reversal Medication (ORM) Act - entire bill requiring employers to keep opioid overdose drugs on site; H.R. 4421 and S. 2333 - Preparing for All Hazards and Pathogens Reauthorization Act - reauthorizes public health medical countermeasures programs; H.R. 8070 - National Defense Authorization bill (NDAA), Fiscal Year 2025 - provisions related to biological and chemical defense and access to Naloxone.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2024-10-17T13:55:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3243708"], "units": {}, "query_ms": 112.90495796129107, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}